Switch View
© BusinessWire
03.11.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck Foundation Launches $22 Million Initiative to Improve Cardiovascular Care in the U.S.
News Preview
The Merck Foundation announced today the launch of the Collaborative for Equity in Cardiac Care, a $22 million, five-year initiative aimed at enhancing access to high-quality, person-centered health care for people living with heart conditions in the U.S. Eleven organizations are receiving grants to support the development and implementation of ev...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder
News Preview
Enrollment completed ahead of schedule, underscoring strong interest from patient community in a potential new therapeutic option...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US10806X1028
BridgeBio Pharma, Inc.
BBIO
LISTED
NASDAQ
BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025
News Preview
PALO ALTO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that ten moderated digital posters will be shared at the American Heart Association (AHA) Scientific Sessions 2025, taking place in New Orle...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
03.11.2025
ISIN: US09062X1037
Biogen Inc
BIIB
LISTED
NASDAQ
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025
News Preview
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – will present new data from its felzartamab clinical development programs at Kidney Week 2025, the American Society of Nephrology’s (ASN) annual meeting, taking place November 5-9 in Houston, Texas. Felzartamab, an investigational anti-CD38 monoclonal antibody, is cur...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
03.11.2025
ISIN: US45779A8466
InspireMD, Inc.
NSPR
LISTED
NASDAQ
InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer
News Preview
MIAMI, Nov. 03, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the appointment of Peter A. Soukas, M.D., as Chief Medical Officer to advance its mission to deliver best-in-class tools for carotid intervention....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US03770N1019
Apogee Therapeutics Inc
APGE
LISTED
NASDAQ
Apogee Therapeutics to Participate in Upcoming Conferences
News Preview
SAN FRANCISCO and BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate at the following investor conferences....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US26818M1080
Dyne Therapeutics Inc
DYN
LISTED
NASDAQ
Dyne Therapeutics to Present at Upcoming Investor Conferences
News Preview
WALTHAM, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that management is scheduled to present at the following upcoming investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US00887A2042
Rein Therapeutics Inc
ALRN
LISTED
NASDAQ
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
News Preview
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US3441741077
Foghorn Therapeutics Inc
FHTX
LISTED
NASDAQ
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
News Preview
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the Guggenheim Second Annual Healthcare Innovation Confere...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US45168D1046
IDEXX Laboratories, Inc.
IDXX
LISTED
NASDAQ
IDEXX Laboratories Announces Third Quarter Results
News Preview
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results.
Third Quarter Results
The Company reports revenues of $1,105 million for the third quarter of 2025, an increase of 13% as reported and 12% organic, driven by Companion Animal Group ("CAG") growth of 14% as reported and...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US8064071025
Henry Schein Inc
HSIC
LISTED
NASDAQ
Henry Schein One and AWS Collaborate to Transform Global Dentistry with Generative AI
News Preview
Henry Schein One, a leading global provider of dental technology, today announced a groundbreaking partnership with Amazon Web Services (AWS), the world’s most comprehensive and broadly adopted cloud platform. Together, the companies will integrate AWS’s generative AI (GenAI) technologies across the Henry Schein One platform — including Dentrix, D...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US8688731004
Surmodics Inc
SRDX
LISTED
NASDAQ
Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3
News Preview
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that Dr. Sean Lyden, Dr. Joseph Campbell, and Dr. Peter Monteleone, will present and discuss updated safety and performance data from the PROWL registry on 160 patients with symptomatic lower extrem...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
03.11.2025
ISIN: US08205P1003
Benitec Biopharma, Inc.
BNTC
LISTED
NASDAQ
Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301
News Preview
HAYWARD, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference (“ddRNAi”) platform, today provides positive interim clinic...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: NL0010696654
Uniqure NV
QURE
LISTED
NASDAQ
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
News Preview
LEXINGTON, Mass. and AMSTERDAM, Nov. 03, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it received feedback from the U.S. Food and Drug Administration (FDA) during a recent pre-Biologics License Application (BLA)...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US5011471027
Krystal Biotech Inc
KRYS
LISTED
NASDAQ
Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results
News Preview
$97.8 million in 3Q VYJUVEK revenue and $623.2 million since U.S. launch...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US05464T1043
Axsome Therapeutics Inc
AXSM
LISTED
NASDAQ
Axsome Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
Total 3Q 2025 net product revenue of $171.0 million, representing 63% year-over-year growth...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US7473241013
Pyxis Oncology Inc
PYXS
LISTED
NASDAQ
Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results
News Preview
- Preliminary data from ongoing Phase 1 clinical studies of micvotabart pelidotin (MICVO) in patients with recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC) expected in the fourth quarter of 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US88322Q1085
TG Therapeutics Inc
TGTX
LISTED
NASDAQ
TG Therapeutics Reports Third Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance
News Preview
Third quarter 2025 total revenue of $161.7 million, including BRIUMVI U.S. net revenue of $152.9 million...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US09058V1035
BioCryst Pharmaceuticals Inc
BCRX
LISTED
NASDAQ
BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
—Q3 2025 ORLADEYO net revenue of $159.1 million (+37 percent y-o-y)— ...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US5015751044
Kymera Therapeutics Inc
KYMR
LISTED
NASDAQ
Kymera Therapeutics to Participate in Upcoming November Investor Conferences
News Preview
WATERTOWN, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the Company will participate in fireside chats at the following upcoming investor events: ...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US0080642061
Jade Biosciences Inc
JBIO
LISTED
NASDAQ
Jade Biosciences to Participate in Upcoming Conferences
News Preview
SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”), (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced its participation in the following upcoming conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US1420381089
Caribou Biosciences Inc
CRBU
LISTED
NASDAQ
Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma
News Preview
BERKELEY, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced its first clinical data from dose escalation in the ongoing CaMMouflage phase 1 trial evaluating CB-011, an off-the-shelf anti-BCMA CAR-T cell therapy, in relapsed...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US61225M1027
Monte Rosa Therapeutics Inc
GLUE
LISTED
NASDAQ
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
News Preview
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US58502B1061
Pediatrix Medical Group Inc
MD
LISTED
NYSE
Pediatrix Medical Group Reports Third Quarter Results
News Preview
Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.84 per share for the three months ended September 30, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.67.
For the 2025 third quarter, Pediatrix reported the following results:
Net revenue of $493 million;
Net i...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: CA05156V1022
Aurinia Pharmaceuticals Inc
AUPH
LISTED
NASDAQ
Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025
News Preview
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that it will report financial results for the three and nine months ended September 30, 2025, and provide an update on recent business progress on November 4, 2025.
Aurinia’s management team will host a webcast and conference call on November 4, 2025, at 8:30 a.m. ET. The link to the we...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US09075V1026
Biontech SE
BNTX
LISTED
NASDAQ
BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update
News Preview
BioNTech SE today reported financial results for the three and nine months ended September 30, 2025 and provide an update on its corporate progress....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: CA72706K1012
Planet 13 Holdings Inc.
PLTH
LISTED
CSE
Planet 13 Streamlines Footprint to Focus on Core Growth Markets
News Preview
Planet 13 Divests Non-Core Orange County Store and Closes Coalinga Cultivation Facility Planet 13 Divests Non-Core Orange County Store and Closes Coalinga Cultivation Facility...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US89854M1018
TScan Therapeutics, Inc.
TCRX
LISTED
NASDAQ
TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027
News Preview
Positive end of Phase I meeting and agreement reached with FDA on pivotal study design for TSC-101...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US53635D2027
Liquidia Corp
LQDA
LISTED
NASDAQ
Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update
News Preview
MORRISVILLE, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today announced its financial results for the third quarter ended September 30, 2025. The company will also ho...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US29358P1012
Ensign Group Inc
ENSG
LISTED
NASDAQ
The Ensign Group Expands in Utah
News Preview
SAN JUAN CAPISTRANO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced to...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US29358P1012
Ensign Group Inc
ENSG
LISTED
NASDAQ
The Ensign Group Adds Operation in Alabama
News Preview
SAN JUAN CAPISTRANO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced to...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Karolinska Development’s portfolio company BOOST Pharma raises SEK 34 million through directed share issue to Sound Bioventures
News Preview
Stockholm, Sweden – November 3, 2025 – Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company BOOST Pharma has raised a SEK 34 million investment structured as a tranched convertible loan from Sound Bioventures.The investment supports continued clinical development of BT-101, a pioneering stem cell-based thera...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
Bristol Myers Squibb Announces Cash Tender Offers to Purchase Certain Notes
News Preview
Bristol-Myers Squibb Company (NYSE: BMY) (“Bristol Myers Squibb” or the “Offeror”), announced the commencement of tender offers (“Offers”) to purchase for cash certain of its outstanding notes (collectively, the “Notes”) as described in the tables below.
Pool 1
Offers to purchase for cash up to $4,000,000,000 aggregate purchase price for the sec...
Themefolio
Profiler
Peergroup
© EQS Newswire
03.11.2025
ISIN: CA68237C1059
Onco-Innovations Limited
ONCO
LISTED
CSE
Onco-Innovations stellt Update für Aktionäre im Anschluss an Cboe Canada Investor Spotlight bereit
News Preview
Schwerpunkt auf US-Strategie
Onco-Innovations Ltd. (ISIN: CA68237C1059 / WKN: A3EKSZ), Onco oder das Unternehmen) freut sich, ein Unternehmensupdate zu geben und die strategischen Ziele für das kommende Jahr darzulegen. Das Update folgt auf den jüngsten Auftritt von Thomas O’Shaughnessy, CEO von Onco-Innovations, bei “Cboe Canada Investor Spotligh......
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH Investors Have Opportunity to Lead Molina Healthcare, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Molina Healthcare, Inc. ("Molina" or "the Company") (NYSE: MOH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Molina Healthcare, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MOH
News Preview
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Molina Healthcare, Inc. ("Molina " or "the Company") (NYSE: MOH ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US80303D3052
SANUWAVE Health, Inc.
SNWV
LISTED
NASDAQ
CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610)
News Preview
CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610)...
Themefolio
Profiler
Peergroup
© EQS Newswire
03.11.2025
ISIN: DE000A1MMCC8
Medios AG
ILM1
LISTED
XETR
Thomas Meier becomes new CEO of Medios AG
News Preview
Press release
Thomas Meier becomes new CEO of Medios AG
Berlin, November 3, 2025 – The Supervisory Board of Medios AG has appointed Thomas Meier as a member of the Executive Board with effect from February 1, 2026, and designated him the new Chief Executive Officer (CEO) of the Company. He succeeds Matthias Gaertner, who will remain in office un......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.11.2025
ISIN: DE000A1MMCC8
Medios AG
ILM1
LISTED
XETR
Thomas Meier wird neuer Vorstandsvorsitzender der Medios AG
News Preview
Pressemitteilung
Thomas Meier wird neuer Vorstandsvorsitzender der Medios AG
Berlin, 3. November 2025 – Der Aufsichtsrat der Medios AG hat Thomas Meier mit Wirkung zum 1. Februar 2026 als Mitglied des Vorstands bestellt und zum neuen Vorsitzenden des Vorstands (CEO) der Gesellschaft ernannt. Er folgt Matthias Gärtner, der bis zum 31. Dezember 2025......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.11.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies, Inc (OTC PINK:MDCE) Announces Development of AI-Powered Wellness App Suite with Global Reach
News Preview
Bringing Next-Generation Wellness to a Global Audience with Multilingual, Accessible AI Solutions MESA, ARIZONA / ACCESS Newswire / November 3, 2025 / Medical Care Technologies, Inc. (OTC Pink:MDCE) is excited to announce the development of its upcoming suite of consumer wellness applications. These AI-driven tools will provide innovative and user-...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR
News Preview
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of aTyr Pharma, Inc. ("aTyr" or "the Company") (NASDAQ: ATYR) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation focuses on w...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cytokinetics, Incorporated ("Cytokinetics" or "the Company") (NASDAQ: CYTK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 a...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH
News Preview
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Lantheus Holdings, Inc. ("Lantheus " or "the Company") (NASDAQ: LNTH ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Sec...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.11.2025
ISIN: US14757U2087
CASI Pharmaceuticals, Inc.
CASI
LISTED
NASDAQ
CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting
News Preview
- CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody- Phase 1 dose escalation study in Immune Thrombocytopenia (ITP) results and update SOUTH SAN FRANCISCO, CA / ACCESS Newswire / November 3, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company developing CID-103, a potential best-in-class, cl...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.11.2025
ISIN: BMG070252017
Altamira Therapeutics Ltd.
CYTO
LISTED
NASDAQ
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules
News Preview
Demonstrated feasibility of effective DNA delivery with Company's xPhore™ nanoparticle technologyDNA delivery technology to be offered as GenePhore™ to biotech / pharma companiesAddressing large and growing market HAMILTON, BERMUDA / ACCESS Newswire / November 3, 2025 / Altamira Therapeutics Ltd. ("Altamira" or the "Compa...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: JP3256000005
Kyowa Kirin Co Ltd
41510
LISTED
XJPX
Kyowa Kirin International Announces Appointment of Julie Dehaene-Puype as President for the Region
News Preview
Kyowa Kirin International (“KKI”), a group company of Kyowa Kirin Co., Ltd. (TSE:4151, “Kyowa Kirin”), a Japan-based Global Specialty Pharmaceutical Company, today announced the appointment of Julie Dehaene-Puype as President for the Region, effective 1 November 2025. Julie follows the tenure of Jeremy Morgan, who has served as President for the I...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SVRA
News Preview
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Savara Inc. ("Savara " or "the Company") (NASDAQ: SVRA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Ex...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Savara Inc. ("Savara" or "the Company") (NASDAQ: SVRA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulg...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.11.2025
ISIN: US45408X3089
IGC Pharma, Inc
IGC
LISTED
XASE
IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline
News Preview
POTOMAC, MARYLAND / ACCESS Newswire / November 3, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's disease, today announced an expansion of its AI-powered in-Silico drug discovery pl...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Avantor, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AVTR
News Preview
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Avantor, Inc. ("Avantor " or "the Company") (NYSE: AVTR ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom" or "the Company") (NASDAQ: DXCM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promul...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
AVTR Investors Have Opportunity to Lead Avantor, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Avantor, Inc. ("Avantor" or "the Company") (NYSE: AVTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promul...
Themefolio
Profiler
Peergroup
© EQS Newswire
03.11.2025
ISIN: MYQ0101OO004
TMC Life Sciences Bhd
TMCLIFE
LISTED
KLS
TMC Life Sciences Poised for Growth Through Strategic Partnerships and Value-Based Care
News Preview
EQS Newswire / 03/11/2025 / 08:30 CET/CEST
PETALING JAYA, MALAYSIA - Media OutReach Newswire - 3 November 2025 - TMC Life Sciences Berhad (TMCLS) remains on track for continued growth in FY2026, following a resilient FY2025 performance anchored by a commitment to clinical excellence, renewed engagement with insurance and corporate partners, st......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.11.2025
ISIN: US88066N3035
Tenon Medical, Inc.
TNON
LISTED
NASDAQ
Tenon Medical, Inc. Announces Timing of Third Quarter 2025 Financial Results
News Preview
LOS GATOS, CA / ACCESS Newswire / November 3, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced plans to release financial results for the third quarter 2025 ended September 30, 2025 after market close on Th...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.11.2025
ISIN: US6300872032
NanoViricides, Inc.
NNVC
LISTED
XASE
NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd
News Preview
SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be presenting today, Monday, November 3rd, at 09:45am ET at the Spartan Capital Investor...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.11.2025
ISIN: US60785L2079
Modular Medical, Inc.
MODD
LISTED
NASDAQ
Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System
News Preview
Key Highlights:Pivot Controller Line Validated: Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch.Pivot will be First Two-Part Tubeless Patch Pump: Pivot, a 3 milliliter removable patch pump, targets the $3 billion dollar market for adult "almost-pumpers" with its affordable, u...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm
News Preview
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. ("Baxter" or "the Company") (NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against aTyr Pharma, Inc. ("aTyr" or "the Company") (NASDAQ: ATYR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 pro...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CYTK
News Preview
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Cytokinetics, Incorporated ("Cytokinetics " or "the Company") (NASDAQ: CYTK ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lantheus Holdings, Inc. ("Lantheus" or "the Company") (NASDAQ: LNTH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
